Access 2.8M+ Filings Sign Up Free
BerGenBio Logo

BerGenBio | BGBIO - Profile, Filings, Stock Info & Investor Relations Data

BerGenBio | BGBIO
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Norway
Founded
2007
BerGenBio (BGBIO)

Company Profile

Website
Investor Relations

About BerGenBio

BerGenBio is a clinical-stage biopharmaceutical company developing innovative drugs for aggressive diseases, including cancer and severe respiratory infections.

AXL: a promising target to treat life-threatening diseases
The tyrosine kinase target AXL is known to play an important role in both the innate and adaptive immune systems, BerGenBio is developing two highly selective AXL inhibitors bemcentinib and tilvestamab.

Business model: R&D excellence and strategic partnerships
BerGenBio is leveraging its solid leadership position in understanding the role of AXL and related kinase signalling in diseases of high unmet need to develop a diversified pipeline of selective AXL inhibitors.

Market Presence

Worldwide

Headquarters

MØLLENDALSBAKKEN 9
5009, BERGEN
Norway

BerGenBio (BGBIO)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

BerGenBio (BGBIO)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

BerGenBio (BGBIO)
Stock & Investor Information

ISINs

NO0012921180
NO0012921495
NO0013251173

LEI

213800TYYFXKYF3V2A23

Stock Exchange Listings

Oslo Børs

Primary Stock Exchange Listing

View BerGenBio on main exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology